Oppenheimer Assumes Cyclacel Pharmaceuticals (CYCC) at Outperform
Tweet
Share
E-mailGet Alerts CYCC Hot Sheet
Price: $6.37 --0%
Rating Summary:
4 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 14 | Down: 11 | New: 17
Rating Summary:
4 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 14 | Down: 11 | New: 17
Join SI Premium – FREE
Oppenheimer analyst Jeff Jones assumes coverage on Cyclacel Pharmaceuticals (NASDAQ: CYCC) with a Outperform rating and a price target of $17.00.
For an analyst ratings summary and ratings history on Cyclacel Pharmaceuticals click here. For more ratings news on Cyclacel Pharmaceuticals click here.
Shares of Cyclacel Pharmaceuticals closed at $1.22 yesterday.
You May Also Be Interested In
- Nomura/Instinet Starts Malayan Cement Bhd (LMC:MK) at Buy
- RBC Capital Starts Costco Wholesale (COST) at Sector Perform
- Nomura/Instinet Starts Weichai Power Co Ltd (000338:CH) (WEICY) at Buy
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
